These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26671078)

  • 1. Camptocormia and Pisa syndrome as manifestations of acute myasthenia gravis exacerbation.
    Abboud H; Sivaraman I; Ontaneda D; Tavee J
    J Neurol Sci; 2015 Dec; 359(1-2):8-10. PubMed ID: 26671078
    [No Abstract]   [Full Text] [Related]  

  • 2. Myasthenia gravis can cause camptocormia.
    Kataoka H; Kiriyama T; Ueno S
    J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):469-70. PubMed ID: 21933949
    [No Abstract]   [Full Text] [Related]  

  • 3. Camptocormia as an onset symptom of myasthenia gravis.
    Sato T; Natori T; Hata T; Yamashiro N; Shindo K; Takiyama Y
    Neurol Sci; 2017 Mar; 38(3):515-516. PubMed ID: 27812759
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of the external oblique muscle in upper camptocormia for patients with Parkinson's disease.
    Furusawa Y; Mukai Y; Kobayashi Y; Sakamoto T; Murata M
    Mov Disord; 2012 May; 27(6):802-3. PubMed ID: 22290442
    [No Abstract]   [Full Text] [Related]  

  • 5. Myopathic camptocormia associated with myasthenia gravis.
    Devic P; Choumert A; Vukusic S; Confavreux C; Petiot P
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1488-9. PubMed ID: 23265561
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and neuroradiological notes on non-extrapyramidal bent spine syndrome.
    Galassi G; Genovese M; Ariatti A; Fini N; De Berti G
    Acta Neurol Belg; 2020 Jun; 120(3):725-727. PubMed ID: 31667794
    [No Abstract]   [Full Text] [Related]  

  • 7. Pisa Syndrome.
    Michel SF; Arias Carrión O; Correa TE; Alejandro PL; Micheli F
    Clin Neuropharmacol; 2015; 38(4):135-40. PubMed ID: 26166239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Camptocormia in idiopathic normal pressure hydrocephalus: a case report.
    Todisco M; Valentino F; Alfonsi E; Cosentino G
    Acta Neurol Belg; 2022 Aug; 122(4):1127-1129. PubMed ID: 33811617
    [No Abstract]   [Full Text] [Related]  

  • 9. Coexistence of chronic inflammatory demyelinating polyneuropathy and camptocormia.
    Terashima M; Kataoka H; Sugie K; Horikawa H; Ueno S
    J Neurol Neurosurg Psychiatry; 2009 Nov; 80(11):1296-7. PubMed ID: 19864667
    [No Abstract]   [Full Text] [Related]  

  • 10. Spontaneous intracranial hypotension with camptocormia.
    Park IS; Kim JS
    Neurology; 2014 May; 82(19):1751. PubMed ID: 24821934
    [No Abstract]   [Full Text] [Related]  

  • 11. Early appearance of camptocormia in motor neuron disease: an association?
    Castrillo Sanz A; Rodríguez Vico J; Hernández Barral M; Duarte García-Luis J
    J Clin Neuromuscul Dis; 2013 Dec; 15(2):43-4. PubMed ID: 24263028
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of Mild Camptocormia with Selegiline in Patients with Parkinson's Disease.
    Yoritaka A; Mori H; Hattori N
    Eur Neurol; 2016; 76(1-2):35-9. PubMed ID: 27351804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of subthalamic deep brain stimulation on posture in Parkinson's disease: A blind computerized analysis.
    Roediger J; Artusi CA; Romagnolo A; Boyne P; Zibetti M; Lopiano L; Espay AJ; Fasano A; Merola A
    Parkinsonism Relat Disord; 2019 May; 62():122-127. PubMed ID: 30638820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Camptocormia: don't forget muscle disease in the movement disorder clinic.
    Doherty KM; Silveira-Moriyama L; Giladi N; Bhatia KP; Parton M; Lees AJ
    J Neurol; 2012 Aug; 259(8):1752-4. PubMed ID: 22349871
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of spinal cord stimulation for painful camptocormia with Pisa syndrome in Parkinson's disease: a case report.
    Akiyama H; Nukui S; Akamatu M; Hasegawa Y; Nishikido O; Inoue S
    BMC Neurol; 2017 Aug; 17(1):148. PubMed ID: 28774283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IVIG Versus PLEX in the Treatment of Worsening Myasthenia Gravis: What is the Evidence?: A Critically Appraised Topic.
    Dhawan PS; Goodman BP; Harper CM; Bosch PE; Hoffman-Snyder CR; Wellik KE; Wingerchuk DM; Demaerschalk BM
    Neurologist; 2015 May; 19(5):145-8. PubMed ID: 25970838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "The bent nuns convent". Antipsycotic-induced Pisa Syndrome and Camptocormia.
    Barriga-Martín A; Romero-Muñoz LM; Caba-Mora D; Rodríguez de Lope-Llorca A; López-Ariztegui N
    Neurocirugia (Astur : Engl Ed); 2021; 32(3):148-152. PubMed ID: 32651057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: a randomized double-blind clinical trial.
    Gajdos P; Tranchant C; Clair B; Bolgert F; Eymard B; Stojkovic T; Attarian S; Chevret S;
    Arch Neurol; 2005 Nov; 62(11):1689-93. PubMed ID: 16286541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive Camptocormia With Head Drop and Dysphagia.
    El-Wahsh S; Triplett J; Yiannikas C
    JAMA Neurol; 2023 Feb; 80(2):209-210. PubMed ID: 36508206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline Decrement in Patients with Mild Myasthenia Gravis Predicts Immunomodulation Treatment.
    Abraham A; Lovblom LE; Bril V
    Can J Neurol Sci; 2019 Nov; 46(6):762-766. PubMed ID: 31322098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.